| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/23/1992 | CA2524168A1 Oral-administration forms of a medicament containing pantoprazole |
| 12/23/1992 | CA2111003A1 Non-chlorofluorocarbon aerosol formulations |
| 12/23/1992 | CA2110487A1 Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes |
| 12/22/1992 | US5173535 Plastics containing sustained release of functional materials |
| 12/22/1992 | US5173512 An aqueous oil-in-water emulsion of perfluoro-N-cyclohexylmorpholine or a mixture with perfluoro-N-hexylmorpholine; synthetic blood |
| 12/22/1992 | US5173488 Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method |
| 12/22/1992 | US5173304 Agents for the treatment of severe pain and preparation of said agents |
| 12/22/1992 | US5173303 Cutaneous delivery of organic materials |
| 12/22/1992 | US5173302 2-acrylamido-2-methyl propanesulfonic acid copolymer, ethylene /propylene oxide derivative humectant, crosslinking monomer, initiator |
| 12/22/1992 | US5173299 Drug active material and polyacrylic acid crosslinked with trimethylpropane triacrylate; swellable |
| 12/22/1992 | US5173298 Nonaqueous fluorinated drug delivery vehicle suspensions |
| 12/22/1992 | US5173291 Dried hydrophobic film of addition polymer complexed with iodine; surgery; bandages; sterilization of skin |
| 12/22/1992 | US5173287 Carboxylic acid compositions |
| 12/22/1992 | US5173219 Uniform spherical multilamellar liposomes of defined and adjustable size distribution |
| 12/22/1992 | CA1311687C Dosage form for delivering diltiazem |
| 12/22/1992 | CA1311686C Controlled release bioerodible drug delivery system |
| 12/19/1992 | CA2071141A1 Megestrol acetate formulation |
| 12/18/1992 | CA2071319A1 Oral diclofenac preparation |
| 12/17/1992 | DE4119140A1 Porous, spongy formed bodies which are soluble in body fluids and secretions - contg. hydrolytically degraded gelatin opt. with collagen hydrolysate(s), softeners, surfactants, etc. useful for admin. of pharmaceutical and cosmetic agents |
| 12/16/1992 | EP0518798A2 Compositions for use in the treatment of aphtous ulcers and other mucocutaneous disorders |
| 12/16/1992 | EP0518697A2 Collagen film for sustained delivery of proteins |
| 12/16/1992 | EP0518601A1 Non-chlorofluorocarbon aerosol formulations |
| 12/16/1992 | EP0518600A1 Non-chlorofluorocarbon aerosol formulations |
| 12/16/1992 | EP0518468A1 Melatonin containing compositions |
| 12/16/1992 | EP0518263A1 Micropellets and a process for their manufacture |
| 12/16/1992 | EP0518113A1 Nitroglycerin-plaster and its preparation |
| 12/16/1992 | EP0517986A1 Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions |
| 12/16/1992 | EP0517970A1 Additive for irrigation solution or surgical solution |
| 12/16/1992 | EP0517840A1 Device and method for administration of physostigmine |
| 12/16/1992 | EP0517829A1 Improved chimeric toxins |
| 12/16/1992 | EP0517771A1 Dispensing device |
| 12/16/1992 | EP0401338A4 Polymeric substrates containing povidone-iodine as a control release biologically active agent |
| 12/16/1992 | CN1066986A Method for refining aqueous extract of traditional chinese medicine |
| 12/16/1992 | CN1066983A Process for preparing medicinal cigarette to cure toothache |
| 12/16/1992 | CN1066979A Preparing method of antibiotics for burn wound |
| 12/16/1992 | CN1066978A Traditional chinese medicine immunity sweets |
| 12/16/1992 | CN1066977A Preparation of diagnostic agents |
| 12/16/1992 | CN1019452B Prepn of warm medicine for external applieation |
| 12/15/1992 | WO1992022306A1 Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions |
| 12/15/1992 | WO1992022304A1 Collagen film drug delivery for proteins |
| 12/15/1992 | US5171812 Polyanhydrides of oligomerized unsaturated aliphatic acids |
| 12/15/1992 | US5171755 Containing water insoluble oil, surfactant; red blood cell substitutes, treating cardiovascular disorders |
| 12/15/1992 | US5171739 Treatment of endotoxin-associated shock and preventation thereof using a BPI protein |
| 12/15/1992 | US5171737 Emulsions |
| 12/15/1992 | US5171580 Orally-pharmaceutical preparations with colon selective delivery |
| 12/15/1992 | US5171578 Administering streptavidin-coupled liposomes |
| 12/15/1992 | US5171577 Process for the preparation of foams which can be used in the cosmetics and pharmaceutical field and foams obtained by this process |
| 12/15/1992 | US5171576 Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug |
| 12/15/1992 | US5171574 Bone collagen matrix for implants |
| 12/15/1992 | US5171571 Effervescent tablet |
| 12/15/1992 | US5171567 Method for the treatment of atll and the inhalant for the same |
| 12/15/1992 | US5171566 Flurbiprofen derivative ophthalmic preparation |
| 12/15/1992 | US5171440 Calcium phosphate |
| 12/15/1992 | US5171217 Method for delivery of smooth muscle cell inhibitors |
| 12/15/1992 | US5171148 Porous mesh containing bone particles |
| 12/15/1992 | CA2102619A1 Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions |
| 12/15/1992 | CA2089487A1 Collagen film drug delivery for proteins |
| 12/15/1992 | CA1311420C Interstitial administration of perfluorochemical emulsions for reoxygenation of hypoxic tumor cells |
| 12/15/1992 | CA1311419C Utilization of otilonium bromide for topical application in the gastrointestinal tract and pharmaceutical formulations appropriate for such use |
| 12/15/1992 | CA1311418C Eyedrops |
| 12/15/1992 | CA1311415C Lipid vesicles formed of surfactants and steroids |
| 12/15/1992 | CA1311388C Process for the preparation of an effervescent granular material, effervescent granular material prepared by this process, as well as the use thereof |
| 12/10/1992 | WO1992021688A1 New perfluoroalkylated amphiphilic phosphorus compounds: preparation and biomedical applications |
| 12/10/1992 | WO1992021670A1 New biotenside ester and phosphatide with vitamin d and vitamin e compounds; their preparation and transformation into spontaneously dispersible concentrates and their use for treating tumors |
| 12/10/1992 | WO1992021378A1 Vaccines with erythrocytes as antigen carriers |
| 12/10/1992 | WO1992021354A1 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 12/10/1992 | WO1992021351A1 Polydeoxyribonucleic acid based pharmaceutical compounds and method for preparing same |
| 12/10/1992 | WO1992021348A1 Pharmaceutical formulations of a benzodiazepine |
| 12/10/1992 | WO1992021338A1 Medetomidine preparations for transdermal administration |
| 12/10/1992 | WO1992021335A1 Phospholipids |
| 12/10/1992 | WO1992021334A1 Pharmaceutical compositions containing 4-substituted imidazoles to be administered transdermally |
| 12/10/1992 | WO1992021332A1 Process for producing therapeutically usable aerosols |
| 12/10/1992 | WO1992021329A1 Biodegradable particulate vector and method of synthesis |
| 12/10/1992 | WO1992021327A1 Microspheres useful for therapeutic vascular occlusions and injectable solutions containing the same |
| 12/10/1992 | WO1992021326A1 Method of producing reproducible particles |
| 12/10/1992 | WO1992021324A1 Pharmaceutical enema preparation |
| 12/10/1992 | WO1992021322A1 Cosmetic or pharmaceutical, particularly dermatological, composition containing a prunella extract |
| 12/10/1992 | WO1992021249A1 Encapsulated bioactive substances |
| 12/10/1992 | WO1992018165A3 Improved fluorocarbon contrast media for use with MRI and radiographic imaging |
| 12/10/1992 | WO1992018111A3 Pharmaceutical composition for the treatment of gastritis |
| 12/10/1992 | DE4118550A1 Animal pharmaceutical for control of pigeon populations - comprises non-resorbable carrier in which substance inhibiting reproduction is uniformly distributed |
| 12/10/1992 | CA2109611A1 Phospholipids |
| 12/10/1992 | CA2088759A1 Biodegradable particulate carrier and generation process therefor |
| 12/09/1992 | EP0517565A2 Process for the preparation of microspheres containing biologically active components |
| 12/09/1992 | EP0517412A1 Pharmaceutical formulations of a benzodiazepine |
| 12/09/1992 | EP0517274A1 Pharmaceutical enema |
| 12/09/1992 | EP0517211A1 Physiologically active polypeptide containing pharmaceutical composition |
| 12/09/1992 | EP0517182A1 Hepatocyte-growth agent |
| 12/09/1992 | EP0517160A1 Extended-release ophthalmic preparations |
| 12/09/1992 | EP0516953A1 Conjugates of liposomes or micro-beads and antibodies specific for T lymphocytes |
| 12/09/1992 | EP0516896A1 Chlortetracycline hydrochloride for use as antiprotozoary preparation for cats and dogs |
| 12/09/1992 | EP0516732A1 Diagnostic aid |
| 12/09/1992 | EP0516685A1 Artificial tears |
| 12/09/1992 | EP0424516B1 Very low temperature casting of controlled release microspheres |
| 12/09/1992 | EP0309464B1 Membrane lipid composition and method for its preparation |
| 12/09/1992 | CN1066790A Non-porous collagen sheet for therapeutic use, and method and apparatus for preparing it |
| 12/09/1992 | CN1066781A Ophthalmic compositions comprising combinations of carbonic anhydrase inhibitor and beta-adrenergic antagonist |
| 12/09/1992 | CN1066780A Capsule filling small and micro tablet producing technology |
| 12/08/1992 | WO1992021325A1 Oral composition based on an antibiotic material and clay |
| 12/08/1992 | US5169967 Aluminum magnesium hydroxy fatty acid compounds and thermostable lipogels including same |